The extended renin-angiotensin system: a promising _target for traumatic brain injury therapeutics
- PMID: 31823875
- PMCID: PMC7034274
- DOI: 10.4103/1673-5374.270304
The extended renin-angiotensin system: a promising _target for traumatic brain injury therapeutics
Conflict of interest statement
None
Figures
Similar articles
-
The role of the brain renin-angiotensin system (RAS) in mild traumatic brain injury (TBI).Pharmacol Ther. 2021 Feb;218:107684. doi: 10.1016/j.pharmthera.2020.107684. Epub 2020 Sep 18. Pharmacol Ther. 2021. PMID: 32956721 Review.
-
Manifestation of renin angiotensin system modulation in traumatic brain injury.Metab Brain Dis. 2021 Aug;36(6):1079-1086. doi: 10.1007/s11011-021-00728-1. Epub 2021 Apr 9. Metab Brain Dis. 2021. PMID: 33835385 Free PMC article. Review.
-
Renin Angiotensin System as a Potential Treatment _target for Traumatic Brain Injury: A Systematic Review and Meta-Analysis.J Neurotrauma. 2022 Apr;39(7-8):473-486. doi: 10.1089/neu.2021.0401. Epub 2022 Feb 11. J Neurotrauma. 2022. PMID: 35029131 Review.
-
Mini-Review: Role of Drugs Affecting Renin-Angiotensin System (RAS) in Traumatic Brain Injury (TBI): What We Know and What We Should Know.Korean J Neurotrauma. 2023 Jun 21;19(2):195-203. doi: 10.13004/kjnt.2023.19.e26. eCollection 2023 Jun. Korean J Neurotrauma. 2023. PMID: 37431373 Free PMC article. Review.
-
The potential role of renin-angiotensin system in mild traumatic brain injury.Neurol Sci. 2022 May;43(5):3353-3359. doi: 10.1007/s10072-021-05856-1. Epub 2022 Jan 4. Neurol Sci. 2022. PMID: 34982298
Cited by
-
Angiotensin-(1-7) reduces α-synuclein aggregation by enhancing autophagic activity in Parkinson's disease.Neural Regen Res. 2022 May;17(5):1138-1145. doi: 10.4103/1673-5374.324854. Neural Regen Res. 2022. PMID: 34558543 Free PMC article.
-
The Angiotensin AT2 Receptor: From a Binding Site to a Novel Therapeutic _target.Pharmacol Rev. 2022 Oct;74(4):1051-1135. doi: 10.1124/pharmrev.120.000281. Pharmacol Rev. 2022. PMID: 36180112 Free PMC article. Review.
-
The Renin Angiotensin System as a Therapeutic _target in Traumatic Brain Injury.Neurotherapeutics. 2023 Oct;20(6):1565-1591. doi: 10.1007/s13311-023-01435-8. Epub 2023 Sep 27. Neurotherapeutics. 2023. PMID: 37759139 Free PMC article. Review.
-
Compound 21, a Direct AT2R Agonist, Induces IL-10 and Inhibits Inflammation in Mice Following Traumatic Brain Injury.Neuromolecular Med. 2022 Sep;24(3):274-278. doi: 10.1007/s12017-021-08687-7. Epub 2021 Sep 20. Neuromolecular Med. 2022. PMID: 34542832 Free PMC article.
-
Transcriptomic Analysis of Mouse Brain After Traumatic Brain Injury Reveals That the Angiotensin Receptor Blocker Candesartan Acts Through Novel Pathways.Front Neurosci. 2021 Mar 22;15:636259. doi: 10.3389/fnins.2021.636259. eCollection 2021. Front Neurosci. 2021. PMID: 33828448 Free PMC article.
References
-
- Janatpour ZC, Korotcov A, Bosomtwi A, Dardzinski BJ, Symes AJ. Subcutaneous administration of angiotensin-(1-7) improves recovery after traumatic brain injury in mice. J Neurotrauma. 2019 doi: 101089/neu20196376. - PubMed
-
- Joseph JP, Mecca AP, Regenhardt RW, Bennion DM, Rodríguez V, Desland F, Patel NA, Pioquinto DJ, Unger T, Katovich MJ, Steckelings UM, Sumners C. The angiotensin type 2 receptor agonist Compound 21 elicits cerebroprotection in endothelin-1 induced ischemic stroke. Neuropharmacology. 2014;81:134–141. - PMC - PubMed
-
- McCarthy CA, Vinh A, Callaway JK, Widdop RE. Angiotensin AT2 receptor stimulation causes neuroprotection in a conscious rat model of stroke. Stroke. 2009;40:1482–1489. - PubMed
Publication types
LinkOut - more resources
Full Text Sources